메뉴 건너뛰기




Volumn 25, Issue 5, 2014, Pages 452-460

Results of a randomized phase i gene therapy clinical trial of nononcolytic fowlpox viruses encoding T cell costimulatory molecules

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIBODY; CD8 ANTIGEN; GENE THERAPY AGENT; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; NONONCOLYTIC FOWLPOX VIRUS; POXVIRUS VECTOR; PROTEIN B7.1; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; CANCER VACCINE; EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; ONCOLYTIC VIRUS; RECOMBINANT VACCINE; RF-B7.1 VACCINE; RF-TRICOM VACCINE;

EID: 84901195478     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2013.217     Document Type: Article
Times cited : (14)

References (27)
  • 2
    • 84884902793 scopus 로고    scopus 로고
    • SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence
    • Grupp, K., Diebel, F., Sirma, H., et al. (2013a). SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence. Prostate 73, 1690-1698.
    • (2013) Prostate , vol.73 , pp. 1690-1698
    • Grupp, K.1    Diebel, F.2    Sirma, H.3
  • 3
    • 84884344385 scopus 로고    scopus 로고
    • Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy
    • Grupp, K., Hohne, T.S., Prien, K., et al. (2013b). Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy. Exp. Mol. Pathol 95, 227-234.
    • (2013) Exp. Mol. Pathol , vol.95 , pp. 227-234
    • Grupp, K.1    Hohne, T.S.2    Prien, K.3
  • 4
    • 49649090374 scopus 로고    scopus 로고
    • Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma
    • Gulley, J.L., Arlen, P.M., Tsang, K.Y., et al. (2008). Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma. Clin. Cancer Res. 14, 3060-3069.
    • (2008) Clin. Cancer Res. , vol.14 , pp. 3060-3069
    • Gulley, J.L.1    Arlen, P.M.2    Tsang, K.Y.3
  • 5
    • 84883458734 scopus 로고    scopus 로고
    • Phase i study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer
    • Gulley, J.L., Heery, C.R., Madan, R.A., et al. (2013). Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer. Cancer Immunol. Immunother. 62, 1521-1531.
    • (2013) Cancer Immunol. Immunother. , vol.62 , pp. 1521-1531
    • Gulley, J.L.1    Heery, C.R.2    Madan, R.A.3
  • 6
    • 0344412934 scopus 로고    scopus 로고
    • Modified Vaccinia Virus Ankara Recombinants Are as Potent as Vaccinia Recombinants in Diversified Prime and Boost Vaccine Regimens to Elicit Therapeutic Antitumor Responses
    • Hodge, J.W., Poole, D.J., Aarts, W.M., et al. (2003). Modified vaccinia virus Ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses. Cancer Res. 63, 7942-7949. (Pubitemid 37466731)
    • (2003) Cancer Research , vol.63 , Issue.22 , pp. 7942-7949
    • Hodge, J.W.1    Poole, D.J.2    Aarts, W.M.3    Yafal, A.G.4    Gritz, L.5    Schlom, J.6
  • 7
    • 77957253429 scopus 로고    scopus 로고
    • OPTIM trial: A phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma
    • Kaufman, H.L., and Bines, S.D. (2010). OPTIM trial: A phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma. Future Oncol. 6, 941-949.
    • (2010) Future Oncol. , vol.6 , pp. 941-949
    • Kaufman, H.L.1    Bines, S.D.2
  • 8
    • 0038359163 scopus 로고    scopus 로고
    • Clinical protocol: Intra-lesional rF-B7.1 versus rF-TRICOM vaccine in the treatment of metastatic cancer
    • Kaufman, H.L., Cheung, K., Haskall, Z., et al. (2003). Clinical protocol: Intra-lesional rF-B7.1 versus rF-TRICOM vaccine in the treatment of metastatic cancer. Hum. Gene Ther. 14, 803-827.
    • (2003) Hum. Gene Ther. , vol.14 , pp. 803-827
    • Kaufman, H.L.1    Cheung, K.2    Haskall, Z.3
  • 9
    • 2942644684 scopus 로고    scopus 로고
    • Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): A trial of the eastern cooperative oncology group
    • Kaufman, H.L., Wang, W., Manola, J., et al. (2004). Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): A trial of the Eastern Cooperative Oncology Group. J. Clin. Oncol. 22, 2122-32.
    • (2004) J. Clin. Oncol. , vol.22 , pp. 2122-2132
    • Kaufman, H.L.1    Wang, W.2    Manola, J.3
  • 10
    • 22144457398 scopus 로고    scopus 로고
    • Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma
    • Kaufman, H.L., Deraffele, G., Mitcham, J., et al. (2005). Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma. J. Clin. Invest. 115, 1903-1912.
    • (2005) J. Clin. Invest. , vol.115 , pp. 1903-1912
    • Kaufman, H.L.1    Deraffele, G.2    Mitcham, J.3
  • 11
    • 33144480152 scopus 로고    scopus 로고
    • Local delivery of vaccinia virus expressing multiple costimulatory molecules for the treatment of established tumors
    • Kaufman, H.L., Cohen, S., Cheung, K., et al. (2006). Local delivery of vaccinia virus expressing multiple costimulatory molecules for the treatment of established tumors. Hum. Gene Ther. 17, 239-244.
    • (2006) Hum. Gene Ther. , vol.17 , pp. 239-244
    • Kaufman, H.L.1    Cohen, S.2    Cheung, K.3
  • 12
    • 77149141965 scopus 로고    scopus 로고
    • Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma
    • Kaufman, H.L., Kim, D.W., Deraffele, G., et al. (2010). Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma. Ann. Surg. Oncol. 17, 718- 730.
    • (2010) Ann. Surg. Oncol. , Issue.17 , pp. 718-730
    • Kaufman, H.L.1    Kim, D.W.2    Deraffele, G.3
  • 13
    • 67650309082 scopus 로고    scopus 로고
    • Gene therapy for antitumor vaccination
    • Kim-Schulze, S., and Kaufman, H.L. (2009). Gene therapy for antitumor vaccination. Methods Mol. Biol. 542, 515-527.
    • (2009) Methods Mol. Biol. , vol.542 , pp. 515-527
    • Kim-Schulze, S.1    Kaufman, H.L.2
  • 14
    • 84879947917 scopus 로고    scopus 로고
    • Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
    • Kluth, M., Hesse, J., Heinl, A., et al. (2013). Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions. Mod. Pathol. 26, 975-983.
    • (2013) Mod. Pathol. , vol.26 , pp. 975-983
    • Kluth, M.1    Hesse, J.2    Heinl, A.3
  • 15
    • 15444372996 scopus 로고    scopus 로고
    • Management of metastatic melanoma to the breast with high-dose interleukin-2 and surgical resection [5]
    • DOI 10.1111/j.1075-122X.2005.21627.x
    • Komenaka, I.K., Deraffele, G., Hurst-Wicker, K.S., and Kaufman H.L. (2005). Management of metastatic melanoma to the breast with high-dose interleukin-2 and surgical resection. Breast J. 11, 158-159. (Pubitemid 40396795)
    • (2005) Breast Journal , vol.11 , Issue.2 , pp. 158-159
    • Komenaka, I.K.1    Deraffele, G.2    Hurst-Wicker, K.S.3    Kaufman, H.L.4
  • 16
    • 0034551730 scopus 로고    scopus 로고
    • Phase i study in advanced cancer patients of a diversified primeand- boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses
    • Marshall, J.L., Hoyer, R.J., Toomey, M.A., et al. (2000). Phase I study in advanced cancer patients of a diversified primeand- boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses. J. Clin. Oncol. 18, 3964-73.
    • (2000) J. Clin. Oncol. , vol.18 , pp. 3964-3973
    • Marshall, J.L.1    Hoyer, R.J.2    Toomey, M.A.3
  • 17
    • 84891428389 scopus 로고    scopus 로고
    • DNA hypermethylation as a predictor of PSA recurrence in patients with low- and intermediate-grade prostate cancer
    • Moritz, R., Ellinger, J., Nuhn, P., et al. (2013). DNA hypermethylation as a predictor of PSA recurrence in patients with low- and intermediate-grade prostate cancer. Anticancer Res. 33, 5249-5254.
    • (2013) Anticancer Res. , vol.33 , pp. 5249-5254
    • Moritz, R.1    Ellinger, J.2    Nuhn, P.3
  • 18
    • 28844444483 scopus 로고    scopus 로고
    • Recent progress in the battle between oncolytic viruses and tumours
    • DOI 10.1038/nrc1750
    • Parato, K.A., Senger, D., Forsyth, P.A., and Bell, J.C. (2005). Recent progress in the battle between oncolytic viruses and tumours. Nat Rev Cancer 5, 965-76. (Pubitemid 41766784)
    • (2005) Nature Reviews Cancer , vol.5 , Issue.12 , pp. 965-976
    • Parato, K.A.1    Senger, D.2    Forsyth, P.A.J.3    Bell, J.C.4
  • 19
    • 0028052724 scopus 로고
    • Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide sidechains
    • Parker, K.C., Bednarek, M.A., and Coligan, J.E. (1994). Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide sidechains. J. Immunol. 152, 163-175.
    • (1994) J. Immunol. , vol.152 , pp. 163-175
    • Parker, K.C.1    Bednarek, M.A.2    Coligan, J.E.3
  • 20
    • 33846894323 scopus 로고    scopus 로고
    • SHIV elicit both neutralizing antibodies and IFNγ-producing T cells against the HIV-envelope protein in mice that control env-bearing tumour cells
    • DOI 10.1016/j.vaccine.2006.11.009, PII S0264410X06011984
    • Radaelli, A., Bonduelle, O., Beggio, P., et al. (2007). Prime- boost immunization with DNA, recombinant fowlpox virus and VLP(SHIV) elicit both neutralizing antibodies and IFNγ-producing T cells against the HIV-envelope protein in mice that control env-bearing tumour cells. Vaccine 25, 2128-2138. (Pubitemid 46227664)
    • (2007) Vaccine , vol.25 , Issue.11 , pp. 2128-2138
    • Radaelli, A.1    Bonduelle, O.2    Beggio, P.3    Mahe, B.4    Pozzi, E.5    Elli, V.6    Paganini, M.7    Zanotto, C.8    Morghen, C.D.G.9    Combadiere, B.10
  • 21
    • 0032866605 scopus 로고    scopus 로고
    • The diversity of T-cell co-stimulation in the induction of antitumor immunity
    • DOI 10.1111/j.1600-065X.1999.tb01330.x
    • Schlom, J., and Hodge, J.W. (1999). The diversity of T-cell costimulation in the induction of antitumor immunity. Immunol. Rev 170, 73-84. (Pubitemid 29490746)
    • (1999) Immunological Reviews , vol.170 , pp. 73-84
    • Schlom, J.1    Hodge, J.W.2
  • 22
    • 73349133717 scopus 로고    scopus 로고
    • Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma
    • Senzer, N.N., Kaufman, H.L., Amatruda, T., et al. (2009). Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma. J. Clin. Oncol. 27, 5763-5771.
    • (2009) J. Clin. Oncol. , vol.27 , pp. 5763-5771
    • Senzer, N.N.1    Kaufman, H.L.2    Amatruda, T.3
  • 24
    • 84879421374 scopus 로고    scopus 로고
    • Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers
    • Stumm, L., Burkhardt, L., Steurer, S., et al. (2013). Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers. J. Clin. Pathol. 66, 563-568.
    • (2013) J. Clin. Pathol. , vol.66 , pp. 563-568
    • Stumm, L.1    Burkhardt, L.2    Steurer, S.3
  • 25
  • 26
    • 0034594628 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors
    • european Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
    • Therasse, P., Arbuck, S.G., Eisenhauer, E.A., et al.; European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. (2000). New guidelines to evaluate the response to treatment in solid tumors. J. Natl. Cancer Inst. 92, 205-216.
    • (2000) J. Natl. Cancer Inst. , vol.92 , pp. 205-216
    • Therasse, P.1    Arbuck, S.G.2    Eisenhauer, E.A.3
  • 27
    • 84882450205 scopus 로고    scopus 로고
    • High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy
    • Tsourlakis, M.C., Walter, E., Quaas, A., et al. (2013). High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy. Prostate Cancer Prostatic Dis. 16, 159- 164.
    • (2013) Prostate Cancer Prostatic Dis. , vol.16 , pp. 159-164
    • Tsourlakis, M.C.1    Walter, E.2    Quaas, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.